...
首页> 外文期刊>Gastroenterology research and practice >Acute Colonic Pseudo-Obstruction with Feeding Intolerance in Critically Ill Patients: A Study according to Gut Wall Analysis
【24h】

Acute Colonic Pseudo-Obstruction with Feeding Intolerance in Critically Ill Patients: A Study according to Gut Wall Analysis

机译:急性结肠伪梗阻,患有患者患者的喂养不耐受性:根据肠壁分析的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective. To compare the differences between acute colonic pseudo-obstruction (ACPO) with and without acute gut wall thickening. Methods. ACPO patients with feeding tolerance were divided into ACPO with no obvious gut wall thickening (ACPO-NT) group and ACPO with obvious acute gut wall thickening (ACPO-T) group according to computed tomography and abdominal radiographs. Patients’ condition, responses to supportive measures, pharmacologic therapy, endoscopic decompression, and surgeries and outcomes were compared. Results. Patients in ACPO-T group had a significantly higher APACHE II (11.82 versus 8.25, p=0.008) and SOFA scores (6.47 versus 3.54, p<0.001) and a significantly higher 28-day mortality (17.78% versus 4.16%, p=0.032) and longer intensive care unit stage (4 versus 16?d, p<0.001). Patients in ACPO-NT group were more likely to be responsive to supportive treatment (62.50% versus 24.44%, p<0.001), neostigmine (77.78% versus 17.64%, p<0.001), and colonoscopic decompression (75% versus 42.86%, p=0.318) than those in ACPO-T group. Of the patients who underwent ileostomy, 81.25% gained benefits. Conclusions. ACPO patients with gut wall thickening are more severe and are less likely to be responsive to nonsurgical treatment. Ileostomy may be a good option for ACPO patients with gut wall thickening who are irresponsive to nonsurgical treatment.
机译:客观的。比较急性结肠伪梗阻(ACPO)与急性肠壁增厚的差异。方法。患有饲养耐受性的ACPO患者分为ACPO,没有明显的肠壁增稠(ACPO-NT)组和ACPO,根据计算机断层扫描和腹部射线照相。患者的病情,对支持性措施,药理治疗,内窥镜减压和手术和结果的反应。结果。 ACPO-T组中的患者具有显着更高的APACHE II(11.82与8.25,P = 0.008)和沙发分数(6.47与3.54,P <0.001)和显着提高的28天死亡率(17.78%,对4.16%,P = 0.032)和更长的重症监护单元阶段(4与16?D,P <0.001)。 ACPO-NT组的患者更可能响应于支持性治疗(62.50%,与24.44%,P <0.001),Neostigmine(77.78%对17.64%,P <0.001)和结肠镜透视减压(75%,而不是42.86%, p = 0.318)比ACPO-T组中的那些。对患者接受了oleoStomy的患者,81.25%的益处。结论。随着齿轮壁增厚的ACPO患者更严重,并且不太可能反应非静电处理。对抗术可能是ACPO患者的肠壁增厚患者的良好选择,谁不适用于非静电处理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号